Combined thin layer chromatography/mass spectrometry: An application of252Cf plasma desorption mass spectrometry for drug monitoring
- 1 September 1985
- journal article
- research article
- Published by Wiley in Journal of Mass Spectrometry
- Vol. 12 (9) , 542-544
- https://doi.org/10.1002/bms.1200120917
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Fractional sampling interface for combined liquid chromatography–mass spectrometry with 252CF fission fragment-induced ionizationJournal of Chromatography A, 1983
- Plasma assay for the antineoplastic agent VP 16-213 (etoposide) using high-performance liquid chromatography with electrochemical detectionJournal of Pharmaceutical and Biomedical Analysis, 1983
- Californium-252 Plasma Desorption Mass SpectrometryAnalytical Chemistry, 1983
- Liquid chromatography/mass spectrometry with 252Cf fission fragment induced ionizationInternational Journal of Mass Spectrometry and Ion Physics, 1983
- Combined liquid chromatography time-of-flight mass spectrometry: An application of252Cf fission fragment induced desorption mass spectrometryJournal of Mass Spectrometry, 1982
- Pharmacokinetics of teniposide (VM26) and etoposide (VP16-213) in children with cancerCancer Chemotherapy and Pharmacology, 1982
- Pharmacokinetics of VP16-213 given by different administration methodsCancer Chemotherapy and Pharmacology, 1982
- The clinical pharmacology of VM26 and VP16-213Cancer Chemotherapy and Pharmacology, 1982
- A sensitive high-performance liquid chromatographic method for determination of the anti-neoplastic agents vp 16-213 and vm 26 in biological fluidsAnalytica Chimica Acta, 1981
- High-performance liquid chromatography determination of 4′-demethyl-epipodophyllotoxin-9-(4,6-O-ethylidene β-d-glucopyranoside) (VP 16-213) in human plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1981